A naukri.com initiative
Eu-Startups
1d
138
Finnish HealthTech startup CurifyLabs raises €6.7 million to make medicine safer and more personalised
- Helsinki-based CurifyLabs has raised €6.7 million to automate compounded medication manufacturing for safer, more personalized medicines.
- The funding round, led by Springvest and funded by Business Finland, aims to optimize medication customization.
- They plan to modernize medication production to suit individual patient needs and improve quality and accuracy in dosages.
- CurifyLabs aims to revolutionize pharmaceutical compounding by automating and speeding up the process, ensuring tailored dosages.
- The company emphasizes the importance of accurate dosages, especially for vulnerable populations like children and cancer patients.
- Their innovative Compounding System Solution combines hardware, software, and quality control to streamline medication production.
- The company's entry into the U.S. market positions them for significant growth in the global compounding industry.
- CurifyLabs launches RoboPharma, a project funded by the EU, to develop a decentralized pharmaceutical manufacturing platform for crisis preparedness.
- The initiative aims to improve the flexibility and reliability of pharmaceutical supply chains during crises and global disruptions.
- Through automated personalized medicine manufacturing, CurifyLabs aims to enhance medication safety, lower pharmacy costs, and adapt to changing healthcare demands.
Read Full Article
8 Likes
For uninterrupted reading, download the app